ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,684,559 | -32.5% | 1,424,403 | -22.4% | 0.18% | -30.4% |
| Q2 2023 | $43,972,631 | +24.1% | 1,836,018 | -2.5% | 0.25% | +16.6% |
| Q1 2023 | $35,425,883 | +35.8% | 1,882,353 | +14.8% | 0.22% | +22.6% |
| Q4 2022 | $26,095,794 | +46.8% | 1,639,183 | +50.9% | 0.18% | +25.5% |
| Q3 2022 | $17,775,000 | +24.4% | 1,086,502 | +84.2% | 0.14% | +46.9% |
| Q1 2022 | $14,283,000 | +13.1% | 589,726 | +9.0% | 0.10% | +12.9% |
| Q4 2021 | $12,628,000 | +49.0% | 541,062 | +6.0% | 0.08% | +49.1% |
| Q3 2021 | $8,475,000 | +1643.8% | 510,228 | +2607.5% | 0.06% | +1325.0% |
| Q1 2021 | $486,000 | – | 18,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |